The promotion of bone healing by progranulin, a downstream molecule of BMP-2, through interacting with TNF/TNFR signaling

Biomaterials

Volumn 34, Issue 27, 2013, Pages 6412-6421

  Zhao, Yun peng ^a   Tian, Qing yun ^a   Frenkel, Sally ^a,b   Liu, Chuan ju ^a,b  

^a NEW YORK UNIVERSITY MEDICAL CENTER   (United States)

^b NEW YORK UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

BMP 2; Bone repair; Bone resorption; Endochondral ossification; Progranulin; TNF

Indexed keywords

BMP-2; BONE REPAIR; BONE RESORPTION; ENDOCHONDRAL OSSIFICATION; PROGRANULIN;

CARTILAGE; MAMMALS; PLANTS (BOTANY); RADIOLOGY;

BONE;

BONE MORPHOGENETIC PROTEIN 2; PROGRANULIN; TUMOR NECROSIS FACTOR; TUMOR NECROSIS FACTOR RECEPTOR; TUMOR NECROSIS FACTOR RECEPTOR 1; TUMOR NECROSIS FACTOR RECEPTOR 2;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BONE DEFECT; BONE REGENERATION; BONE REMODELING; CONTROLLED STUDY; ENCHONDRAL OSSIFICATION; IMMUNOHISTOCHEMISTRY; MALE; MICRO-COMPUTED TOMOGRAPHY; MOUSE; NONHUMAN; OSTEOCLASTOGENESIS; OSTEOLYSIS; PRIORITY JOURNAL; PROTEIN INTERACTION; X RAY;

ANIMALS; CELL LINE; CELLS, CULTURED; FEMORAL FRACTURES; FEMUR; FRACTURE HEALING; GENE DELETION; INTERCELLULAR SIGNALING PEPTIDES AND PROTEINS; MALE; MICE; MICE, TRANSGENIC; OSTEOGENESIS; RECEPTORS, TUMOR NECROSIS FACTOR; RECOMBINANT PROTEINS; SIGNAL TRANSDUCTION; TUMOR NECROSIS FACTOR-ALPHA;

MUS; MUS MUSCULUS;

EID: 84879084602     PISSN: 01429612     EISSN: 18785905     Source Type: Journal    
DOI: 10.1016/j.biomaterials.2013.05.030     Document Type: Article

References (63)

1. Soung do Y., Talebian L., Matheny C.J., Guzzo R., Speck M.E., Lieberman J.R., et al. Runx1 dose-dependently regulates endochondral ossification during skeletal development and fracture healing. JBone Miner Res 2012, 27:1585-1597.
2. Mi M., Jin H., Wang B., Yukata K., Sheu T.J., Ke Q.H., et al. Chondrocyte BMP2 signaling plays an essential role in bone fracture healing. Gene 2013, 512:211-218.
3. Siu R.K., Zara J.N., Hou Y., James A.W., Kwak J., Zhang X., et al. NELL-1 promotes cartilage regeneration in an invivo rabbit model. Tissue Eng Part A 2012, 18:252-261.
4. Siu R.K., Lu S.S., Li W., Whang J., McNeill G., Zhang X., et al. Nell-1 protein promotes bone formation in a sheep spinal fusion model. Tissue Eng Part A 2011, 17:1123-1135.
5. Cha B.H., Kim J.H., Kang S.W., Do H.J., Jang J.W., Choi Y.R., et al. Cartilage tissue formation from dedifferentiated chondrocytes by codelivery of BMP-2 and SOX-9 genes encoding bicistronic vector. Cell Transplant 2012, [Epub ahead of print].
6. Ben-David D., Srouji S., Shapira-Schweitzer K., Kossover O., Ivanir E., Kuhn G., et al. Low dose BMP-2 treatment for bone repair using a PEGylated fibrinogen hydrogel matrix. Biomaterials 2013, 34:2902-2910.
7. Lin G.L., Hankenson K.D. Integration of BMP, Wnt, and notch signaling pathways in osteoblast differentiation. JCell Biochem 2011, 112:3491-3501.
8. Bandyopadhyay A., Tsuji K., Cox K., Harfe B.D., Rosen V., Tabin C.J. Genetic analysis of the roles of BMP2, BMP4, and BMP7 in limb patterning and skeletogenesis. PLoS Genet 2006, 2:e216.
9. Tsuji K., Bandyopadhyay A., Harfe B.D., Cox K., Kakar S., Gerstenfeld L., et al. BMP2 activity, although dispensable for bone formation, is required for the initiation of fracture healing. Nat Genet 2006, 38:1424-1429.
10. McKay W.F., Peckham S.M., Badura J.M. Acomprehensive clinical review of recombinant human bone morphogenetic protein-2 (INFUSE bone graft). Int Orthop 2007, 31:729-734.
11. Gerstenfeld L.C., Cho T.J., Kon T., Aizawa T., Tsay A., Fitch J., et al. Impaired fracture healing in the absence of TNF-alpha signaling: the role of TNF-alpha in endochondral cartilage resorption. JBone Miner Res 2003, 18:1584-1592.
12. Gerstenfeld L.C., Cho T.J., Kon T., Aizawa T., Cruceta J., Graves B.D., et al. Impaired intramembranous bone formation during bone repair in the absence of tumor necrosis factor-alpha signaling. Cells Tissues Organs 2001, 169:285-294.
13. Eguchi Y., Wakitani S., Imai Y., Naka Y., Hashimoto Y., Nakamura H., et al. Antitumor necrotic factor agent promotes BMP-2-induced ectopic bone formation. JBone Miner Metab 2010, 28:157-164.
14. Wahl E.C., Aronson J., Liu L., Skinner R.A., Miller M.J., Cockrell G.E., et al. Direct bone formation during distraction osteogenesis does not require TNFalpha receptors and elevated serum TNFalpha fails to inhibit bone formation in TNFR1 deficient mice. Bone 2010, 46:410-417.
15. Liu Y., Wang L., Kikuiri T., Akiyama K., Chen C., Xu X., et al. Mesenchymal stem cell-based tissue regeneration is governed by recipient T lymphocytes via IFN-gamma and TNF-alpha. Nat Med 2011, 17:1594-1601.
16. Zanocco-Marani T., Bateman A., Romano G., Valentinis B., He Z.H., Baserga R. Biological activities and signaling pathways of the granulin/epithelin precursor. Cancer Res 1999, 59:5331-5340.
17. Shoyab M., McDonald V.L., Byles C., Todaro G.J., Plowman G.D. Epithelins 1 and 2: isolation and characterization of two cysteine-rich growth-modulating proteins. Proc Natl Acad Sci USA 1990, 87:7912-7916.
18. Plowman G.D., Green J.M., Neubauer M.G., Buckley S.D., McDonald V.L., Todaro G.J., et al. The epithelin precursor encodes two proteins with opposing activities on epithelial cell growth. JBiol Chem 1992, 267:13073-13078.
19. Anakwe O.O., Gerton G.L. Acrosome biogenesis begins during meiosis: evidence from the synthesis and distribution of an acrosomal glycoprotein, acrogranin, during guinea pig spermatogenesis. Biol Reprod 1990, 42:317-328.
20. Zhou J., Gao G., Crabb J.W., Serrero G. Purification of an autocrine growth factor homologous with mouse epithelin precursor from a highly tumorigenic cell line. JBiol Chem 1993, 268:10863-10869.
21. Hrabal R., Chen Z., James S., Bennett H.P., Ni F. The hairpin stack fold, a novel protein architecture for a new family of protein growth factors. Nat Struct Biol 1996, 3:747-752.
22. Butler G.S., Dean R.A., Tam E.M., Overall C.M. Pharmacoproteomics of a metalloproteinase hydroxamate inhibitor in breast cancer cells: dynamics of membrane type 1 matrix metalloproteinase-mediated membrane protein shedding. Mol Cell Biol 2008, 28:4896-4914.
23. Suh H.S., Choi N., Tarassishin L., Lee S.C. Regulation of progranulin expression in human microglia and proteolysis of progranulin by matrix metalloproteinase-12 (MMP-12). PloS One 2012, 7:e35115.
24. Xu D., Suenaga N., Edelmann M.J., Fridman R., Muschel R.J., Kessler B.M. Novel MMP-9 substrates in cancer cells revealed by a label-free quantitative proteomics approach. Mol Cell Proteomics 2008, 7:2215-2228.
25. Kessenbrock K., Frohlich L., Sixt M., Lammermann T., Pfister H., Bateman A., et al. Proteinase 3 and neutrophil elastase enhance inflammation in mice by inactivating antiinflammatory progranulin. JClin Invest 2008, 118:2438-2447.
26. Zhu J., Nathan C., Jin W., Sim D., Ashcroft G.S., Wahl S.M., et al. Conversion of proepithelin to epithelins: roles of SLPI and elastase in host defense and wound repair. Cell 2002, 111:867-878.
27. Liu C.J., Bosch X. Progranulin: a growth factor, a novel TNFR ligand and a drug target. Pharmacol Ther 2012, 133:124-132.
28. Liu C.J. Progranulin: a promising therapeutic target for rheumatoid arthritis. FEBS Lett 2011, 585:3675-3680.
29. He Z., Ong C.H., Halper J., Bateman A. Progranulin is a mediator of the wound response. Nat Med 2003, 9:225-229.
30. Bateman A., Bennett H.P. The granulin gene family: from cancer to dementia. Bioessays 2009, 31:1245-1254.
31. Baker M., Mackenzie I.R., Pickering-Brown S.M., Gass J., Rademakers R., Lindholm C., et al. Mutations in progranulin cause tau-negative frontotemporal dementia linked to chromosome 17. Nature 2006, 442:916-919.
32. Cruts M., Gijselinck I., van der Zee J., Engelborghs S., Wils H., Pirici D., et al. Null mutations in progranulin cause ubiquitin-positive frontotemporal dementia linked to chromosome 17q21. Nature 2006, 442:920-924.
33. Wils H., Kleinberger G., Pereson S., Janssens J., Capell A., Van Dam D., et al. Cellular ageing, increased mortality and FTLD-TDP-associated neuropathology in progranulin knockout mice. JPathol 2012, 228(1):67-76.
34. Yin F., Banerjee R., Thomas B., Zhou P., Qian L., Jia T., et al. Exaggerated inflammation, impaired host defense, and neuropathology in progranulin-deficient mice. JExp Med 2010, 207:117-128.
35. Tang W., Lu Y., Tian Q.Y., Zhang Y., Guo F.J., Liu G.Y., et al. The growth factor progranulin binds to TNF receptors and is therapeutic against inflammatory arthritis in mice. Science 2011, 332:478-484.
36. Jian J., Konopka J., Liu C. Insights into the role of progranulin in immunity, infection, and inflammation. JLeukoc Biol 2013, 93:199-208.
37. Guo F., Lai Y., Tian Q., Lin E.A., Kong L., Liu C. Granulin-epithelin precursor binds directly to ADAMTS-7 and ADAMTS-12 and inhibits their degradation of cartilage oligomeric matrix protein. Arthritis Rheum 2010, 62:2023-2036.
38. Xu K., Zhang Y., Ilalov K., Carlson C.S., Feng J.Q., Di Cesare P.E., et al. Cartilage oligomeric matrix protein associates with granulin-epithelin precursor (GEP) and potentiates GEP-stimulated chondrocyte proliferation. JBiol Chem 2007, 282:11347-11355.
39. Bai X.H., Wang D.W., Kong L., Zhang Y., Luan Y., Kobayashi T., et al. ADAMTS-7, a direct target of PTHrP, adversely regulates endochondral bone growth by associating with and inactivating GEP growth factor. Mol Cell Biol 2009, 29:4201-4219.
40. Feng J.Q., Guo F.J., Jiang B.C., Zhang Y., Frenkel S., Wang D.W., et al. Granulin epithelin precursor: a bone morphogenic protein 2-inducible growth factor that activates Erk1/2 signaling and JunB transcription factor in chondrogenesis. FASEB J 2010, 24:1879-1892.
41. Wu H., Siegel R.M. Progranulin resolves inflammation. Science 2011, 332:427-428.
42. Lin E.A., Liu C.J., Monroy A., Khurana S., Egol K.A. Prevention of atrophic nonunion by the systemic administration of parathyroid hormone (PTH 1-34) in an experimental animal model. JOrthop Trauma 2012, 26:719-723.
43. Garcia P., Holstein J.H., Maier S., Schaumloffel H., Al-Marrawi F., Hannig M., et al. Development of a reliable non-union model in mice. JSurg Res 2008, 147:84-91.
44. He Y.X., Zhang G., Pan X.H., Liu Z., Zheng L.Z., Chan C.W., et al. Impaired bone healing pattern in mice with ovariectomy-induced osteoporosis: a drill-hole defect model. Bone 2011, 48:1388-1400.
45. Kimelman-Bleich N., Pelled G., Sheyn D., Kallai I., Zilberman Y., Mizrahi O., et al. The use of a synthetic oxygen carrier-enriched hydrogel to enhance mesenchymal stem cell-based bone formation invivo. Biomaterials 2009, 30:4639-4648.
46. Shimono K., Tung W.E., Macolino C., Chi A.H., Didizian J.H., Mundy C., et al. Potent inhibition of heterotopic ossification by nuclear retinoic acid receptor-gamma agonists. Nat Med 2011, 17:454-460.
47. Zhu F., Sweetwyne M.T., Hankenson K.D. Pkcdelta is required for jagged-1 induction of hMSC osteogenic differentiation. Stem Cells 2013, [Epub ahead of print]. 10.1002/stem.1353.
48. Yang Q., Jian J., Abramson S.B., Huang X. Inhibitory effects of iron on bone morphogenetic protein 2-induced osteoblastogenesis. JBone Miner Res 2011, 26:1188-1196.
49. Holstein J.H., Orth M., Scheuer C., Tami A., Becker S.C., Garcia P., et al. Erythropoietin stimulates bone formation, cell proliferation, and angiogenesis in a femoral segmental defect model in mice. Bone 2011, 49:1037-1045.
50. Manaka T., Suzuki A., Takayama K., Imai Y., Nakamura H., Takaoka K. Local delivery of siRNA using a biodegradable polymer application to enhance BMP-induced bone formation. Biomaterials 2011, 32:9642-9648.
51. Ushiku C., Adams D.J., Jiang X., Wang L., Rowe D.W. Long bone fracture repair in mice harboring GFP reporters for cells within the osteoblastic lineage. JOrthop Res 2010, 28:1338-1347.
52. Colnot C. Skeletal cell fate decisions within periosteum and bone marrow during bone regeneration. JBone Miner Res 2009, 24:274-282.
53. Kawanami A., Matsushita T., Chan Y.Y., Murakami S. Mice expressing GFP and CreER in osteochondro progenitor cells in the periosteum. Biochem Biophys Res Commun 2009, 386:477-482.
54. Lu C., Miclau T., Hu D., Hansen E., Tsui K., Puttlitz C., et al. Cellular basis for age-related changes in fracture repair. JOrthop Res 2005, 23:1300-1307.
55. Naik A.A., Xie C., Zuscik M.J., Kingsley P., Schwarz E.M., Awad H., et al. Reduced COX-2 expression in aged mice is associated with impaired fracture healing. JBone Miner Res 2009, 24:251-264.
56. Chen C., Uludag H., Wang Z., Jiang H. Noggin suppression decreases BMP-2-induced osteogenesis of human bone marrow-derived mesenchymal stem cells invitro. JCell Biochem 2012, 113:3672-3680.
57. Pera M.F., Andrade J., Houssami S., Reubinoff B., Trounson A., Stanley E.G., et al. Regulation of human embryonic stem cell differentiation by BMP-2 and its antagonist noggin. JCell Sci 2004, 117:1269-1280.
58. Zhao B., Grimes S.N., Li S., Hu X., Ivashkiv L.B. TNF-induced osteoclastogenesis and inflammatory bone resorption are inhibited by transcription factor RBP-J. JExp Med 2012, 209:319-334.
59. Pacios S., Kang J., Galicia J., Gluck K., Patel H., Ovaydi-Mandel A., et al. Diabetes aggravates periodontitis by limiting repair through enhanced inflammation. FASEB J 2012, 26:1423-1430.
60. Pirih F., Lu J., Ye F., Bezouglaia O., Atti E., Ascenzi M.G., et al. Adverse effects of hyperlipidemia on bone regeneration and strength. JBone Miner Res 2012, 27:309-318.
61. Abu-Amer Y., Ross F.P., Edwards J., Teitelbaum S.L. Lipopolysaccharide-stimulated osteoclastogenesis is mediated by tumor necrosis factor via its P55 receptor. JClin Invest 1997, 100:1557-1565.
62. Zou W., Hakim I., Tschoep K., Endres S., Bar-Shavit Z. Tumor necrosis factor-alpha mediates RANK ligand stimulation of osteoclast differentiation by an autocrine mechanism. JCell Biochem 2001, 83:70-83.
63. Roggia C., Gao Y., Cenci S., Weitzmann M.N., Toraldo G., Isaia G., et al. Up-regulation of TNF-producing T cells in the bone marrow: a key mechanism by which estrogen deficiency induces bone loss invivo. Proc Natl Acad Sci USA 2001, 98:13960-13965.